Evidence map›Paper›PMID 40715093›Full record

ArticleNature communications2025

Biomarkers of pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis through single-cell transcriptomics.

Jie Shen, Yunyan He, Hong Zheng, Jianwen Xiao, Fu Li, Keke Chen, Biyun Guo, Yulei He, Lin Liu, Zhi Lin and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jie Shen *Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yunyan He *Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Hong ZhengDepartment of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID http://orcid.org/0000-0002-8271-9320
Jianwen XiaoDepartment of Pediatrics, Children Hospital of Chongqing Medical University, Chongqing, China.
Fu LiDepartment of Hematology and Oncology, Children's Hospital Affiliated to Shandong University and Jinan Children's Hospital, Jinan, Shandong, China.
Keke ChenDepartment of Pediatric Hematology and Oncology, School of Medicine, Children's Medical Center of Hunan Provincial People's Hospital of the First-Affiliated Hospital, Changsha, Hunan, China.
Biyun GuoDepartment of Pediatrics, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
Yulei HeHealth Management Center, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Lin LiuDepartment of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhi LinDepartment of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.ORCID http://orcid.org/0000-0002-1802-6415
Dan WangDepartment of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Leping LiuDepartment of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Shengfeng WangDepartment of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wen ZhouCancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.ORCID http://orcid.org/0000-0003-0834-9306
Yingchi ZhangState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Jian WeiDepartment of Pediatrics, Xiangxi Autonomous Prefecture People's Hospital, Jishou, Hunan, China.
Yunchu WangDepartment of Pediatrics, Liuyang people's hospital, Changsha, Hunan, China.
Rong HuDepartment of Pediatrics, The First People's Hospital of Changde City, Changde, China.
Daolin TangDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-1903-6180
Dao WangDepartment of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. deai315@163.com.
Minghua YangDepartment of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan, China. yangminghua@csu.edu.cn.ORCID http://orcid.org/0000-0003-3746-1209

Funding

China Primary Health Care Foundation (Primary Health Care Foundation of China) xyxthjb-2023-004National Natural Science Foundation of China (National Science Foundation of China) 82270185National Natural Science Foundation of China (National Science Foundation of China) 82400213
6 · The paper itself

Abstract

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) is a fatal hyperinflammatory disorder distinct from self-limiting EBV-induced infectious mononucleosis (IM). However, the immunological mechanisms underlying the divergence between benign EBV infection and fulminant HLH-particularly in the absence of inherited immunodeficiency-remains unclear, and systematic comparisons of immune landscapes across EBV-associated disease spectra are lacking. In this study, by enrolling children with IM and healthy volunteers as controls, we utilize single-cell RNA sequencing to identify unique immunological characteristics of EBV-HLH. Our analysis indicates that patients with EBV-HLH exhibite widespread activation of NF-κB signaling pathway. Furthermore, excessive cytokine secretion by T and NK cells is observed, along with a shift in monocyte differentiation towards an inflammatory phenotype, and the aggregation of IDO1

Indexed as

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanLymphohistiocytosis, HemophagocyticTranscriptomeAdolescentBiomarkersCase-Control StudiesChildChild, PreschoolCytokinesFemaleGene Expression ProfilingHumansIndoleamine-Pyrrole 2,3,-DioxygenaseInfantInfectious MononucleosisBiomarkersCytokinesIDO1 protein, humanIndoleamine-Pyrrole 2,3,-DioxygenaseNF-kappa B

Identifiers

PMID40715093
PMCPMC12297430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.